Amgen faces major revenue risk from upcoming patent cliffs but has promising pipeline drugs to offset losses. Learn why AMGN stock is a Buy.

A federal judge said Amgen must face a proposed class action accusing the drugmaker of waiting too long to tell shareholders it might owe the Internal Revenue Service $10.7 billion for ...

An apprenticeship with Columbus State Community College led to high-paying jobs at Amgen's New Albany plant.

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win.

Topline The Federal Trade Commission announced Friday it had reached a settlement with Amgen Inc. over the biopharmaceutical firm’s $27.8 billion acquisition of Horizon Therapeutics, after the ...

Amgen Inc. AMGN -0.44% agreed to acquire Horizon Therapeutics PLC for $27.8 billion, marking the largest healthcare merger of the year. Under the terms of the deal, which was first reported by The ...

Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms Amgen’s MariTide achieves up to 20% weight loss in mid-stage trial, but analysts were ...

Amgen expands its New Albany biopharmaceutical campus with a $900 million investment, creating 750 high-paying jobs in Ohio by 2027.

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 5.3% in the morning session after the company reported strong fourth-quarter results. Amgen exceeded analysts' revenue expectations this ...

Biotech company Amgen announced on April 25, 2025, a $900-million expansion of its New Albany manufacturing facility that will add 350 jobs.

Amgen said Tuesday that the Food and Drug Administration has ordered a hold on a study of the company’s early-stage obesity candidate, another potential setback in the company’s efforts to ...